Feinstein Institutes for Medical research Archives

Tag: Feinstein Institutes for Medical research

Lupus Research Alliance Awards $9 Million to Develop Lupus Treatment Breakthroughs

NEW YORK, NY – August 24, 2022 – The Lupus Research Alliance (LRA) today announced its Global Team Science Award (GTSA) has been granted to three international research teams from 14 institutions across four continents comprised of leading experts spanning in immunology, rheumatology, neurosciences, biomedical engineering, genomics and genetics, and public health. With $3 million […] Read More

Helping Overcome Lupus Effects on Mental Health

Updated March 11, 2022 Neuropsychiatric lupus affects 80-90% of people with lupus. In a video series hosted by the Young Leaders Board of the Lupus Research Alliance, Dr. Meggan Mackay explains How to know if you have neuropsychiatric lupus and offers ways to improve cognitive health. Dr. Mackay also describes a clinical trial she is […] Read More

2018 LRA Lupus Insight Prize Recipient Receives $15 M Grant from NIH to Study Lupus Effects on the Brain

July 27, 2020 The Lupus Research Alliance congratulates 2018 Lupus Insight Prize recipient Betty Diamond, MD and the Feinstein Institutes for Medical Research on being awarded $15 million from the National Institute of Allergy and Infectious Disease to study brain dysfunction linked to lupus. Dr. Diamond will use the five-year grant to study a receptor […] Read More

Independent Panel Gives High Marks to New Lupus Nephritis Therapies, Policies Reflect LRA Feedback

April 20, 2021 At a public meeting in March led by the Institute for Clinical and Economic Review (ICER), an independent panel voted unanimously that both belimumab (Benlysta) and voclosporin (Lupkynis), newly approved to treat lupus nephritis, provide a health benefit over standard therapy alone. ICER’s policy recommendations for the use of these two medications […] Read More

Taking Scientific Discovery: From Lab Bench to You

April, 2019 Making new and efficacious lupus therapies available to patients has long been a major focus of the Lupus Research Alliance, and today we’ve taken an important step toward that aim. Based on a breakthrough discovery made by Betty Diamond, MD of Feinstein Institutes for Medical Research, Meggan Mackay, MD, MS, also at Feinstein, will […] Read More

Lupus Research Alliance Congratulates Dr. Betty Diamond for Well-Deserved Recognition by AAI

May 20, 2019 The LRA applauds Betty Diamond, MD for being named a Distinguished Fellow by the American Association of Immunologists (AAI) at their 2019 annual meeting. A top expert in lupus and autoimmune disease, Dr. Diamond co-chairs a committee of our affiliate Lupus Therapeutics Lupus Clinical Investigators Network (LuCIN) that evaluates drugs to be […] Read More